Annual Accounts Payable
$9.48 M
+$6.69 M+239.89%
December 31, 2023
Summary
- As of February 7, 2025, DNLI annual accounts payable is $9.48 million, with the most recent change of +$6.69 million (+239.89%) on December 31, 2023.
- During the last 3 years, DNLI annual accounts payable has risen by +$8.41 million (+785.43%).
- DNLI annual accounts payable is now at all-time high.
Performance
DNLI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$9.59 M
-$4.34 M-31.16%
September 30, 2024
Summary
- As of February 7, 2025, DNLI quarterly accounts payable is $9.59 million, with the most recent change of -$4.34 million (-31.16%) on September 30, 2024.
- Over the past year, DNLI quarterly accounts payable has dropped by -$4.34 million (-31.16%).
- DNLI quarterly accounts payable is now -31.16% below its all-time high of $13.94 million, reached on June 30, 2024.
Performance
DNLI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
DNLI Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +239.9% | -31.2% |
| 3 y3 years | +785.4% | +243.9% |
| 5 y5 years | +401.5% | +243.9% |
DNLI Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +239.9% | -31.2% | +711.7% |
| 5 y | 5-year | at high | +785.4% | -31.2% | +795.8% |
| alltime | all time | at high | +785.4% | -31.2% | +795.8% |
Denali Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.59 M(-31.2%) |
| Jun 2024 | - | $13.94 M(+17.6%) |
| Mar 2024 | - | $11.86 M(+25.0%) |
| Dec 2023 | $9.48 M(+239.9%) | $9.48 M(+702.3%) |
| Sep 2023 | - | $1.18 M(-86.1%) |
| Jun 2023 | - | $8.52 M(+284.7%) |
| Mar 2023 | - | $2.21 M(-20.6%) |
| Dec 2022 | $2.79 M(-41.6%) | $2.79 M(-63.0%) |
| Sep 2022 | - | $7.54 M(+5.9%) |
| Jun 2022 | - | $7.12 M(+111.9%) |
| Mar 2022 | - | $3.36 M(-29.7%) |
| Dec 2021 | $4.78 M(+346.2%) | $4.78 M(-0.8%) |
| Sep 2021 | - | $4.82 M(+13.7%) |
| Jun 2021 | - | $4.24 M(+160.5%) |
| Mar 2021 | - | $1.63 M(+51.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $1.07 M(-58.6%) | $1.07 M(-61.8%) |
| Sep 2020 | - | $2.81 M(+50.4%) |
| Jun 2020 | - | $1.87 M(-19.4%) |
| Mar 2020 | - | $2.32 M(-10.6%) |
| Dec 2019 | $2.59 M(+37.0%) | $2.59 M(+28.1%) |
| Sep 2019 | - | $2.02 M(-48.6%) |
| Jun 2019 | - | $3.93 M(+7.3%) |
| Mar 2019 | - | $3.66 M(+93.7%) |
| Dec 2018 | $1.89 M(-30.4%) | $1.89 M(-43.6%) |
| Sep 2018 | - | $3.35 M(-63.4%) |
| Jun 2018 | - | $9.18 M(+566.4%) |
| Mar 2018 | - | $1.38 M(-49.3%) |
| Dec 2017 | $2.72 M(+38.4%) | $2.72 M(+19.6%) |
| Sep 2017 | - | $2.27 M(+15.6%) |
| Dec 2016 | $1.96 M(+14.6%) | $1.96 M |
| Dec 2015 | $1.71 M | - |
FAQ
- What is Denali Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Denali Therapeutics?
- What is Denali Therapeutics annual accounts payable year-on-year change?
- What is Denali Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Denali Therapeutics?
- What is Denali Therapeutics quarterly accounts payable year-on-year change?
What is Denali Therapeutics annual accounts payable?
The current annual accounts payable of DNLI is $9.48 M
What is the all time high annual accounts payable for Denali Therapeutics?
Denali Therapeutics all-time high annual accounts payable is $9.48 M
What is Denali Therapeutics annual accounts payable year-on-year change?
Over the past year, DNLI annual accounts payable has changed by +$6.69 M (+239.89%)
What is Denali Therapeutics quarterly accounts payable?
The current quarterly accounts payable of DNLI is $9.59 M
What is the all time high quarterly accounts payable for Denali Therapeutics?
Denali Therapeutics all-time high quarterly accounts payable is $13.94 M
What is Denali Therapeutics quarterly accounts payable year-on-year change?
Over the past year, DNLI quarterly accounts payable has changed by -$4.34 M (-31.16%)